Search for: "AbbVie Deutschland GmbH & Co. v. Janssen Biotech, Inc." Results 1 - 9 of 9
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
AbbVie Deutschland GmbH v. Janssen Biotech, Inc. (Fed. Cir. 2014)
10 Jul 2014, 9:59 pm by Patent Docs
Janssen Biotech, Inc., the Federal Circuit affirmed judgments by the District Court for the District of Massachusetts in infringement and interference actions involving AbbVie Deutschland GmbH & Co., KG; AbbVie Bioresearch Center, Inc.; and AbbVie Biotechnology Ltd. [read post]
Patent Docs - http://www.patentdocs.org/
Abbvie Deutschland GMBH & Co. v. Janssen Biotech, Inc.: Board Decision Not Final for Collateral Estoppel
12 Aug 2014, 8:00 pm
Janssen Biotech, Inc., No. 2013-1338, 1346 (Fed. [read post]
Journal of the Patent and Trademark Office Society - http://jptos.org
CAFC discusses written description in Flashcontrol, LLC
16 Jul 2021, 12:53 pm by Lawrence B. Ebert
” AbbVie Deutschland GmbH & Co. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Biogen loses to Mylan in request for rehearing over issues in patent for multiple sclerosis [MS] drug related to fumarates
17 Mar 2022, 2:32 pm by Lawrence B. Ebert
See Abbvie Deutschland GmbH & Co. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Functional Claiming of Antibodies: (Continue to) Proceed With Caution
6 Oct 2017, 2:34 pm by Aaron Barkoff
Mass. 2013) and Abbvie Deutschland GmbH v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Functional Claiming of Antibodies: (Continue to) Proceed With Caution
6 Oct 2017, 2:34 pm by Aaron Barkoff
Mass. 2013) and Abbvie Deutschland GmbH v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Federal Circuit Affirms Invalidity of Genus Claims to Stevia Production Method Lacking Written Description and Narrower Claims as Combining Natural Phenomena with an Abstract Idea
4 Jan 2024, 9:42 am by Dennis Crouch
As in other Federal Circuit decisions like AbbVie Deutschland GmbH & Co., KG v. [read post]
Patently-O - https://patentlyo.com
What is Next for Enablement and Written Description of Antibody Claims?
23 Apr 2024, 10:28 am by Dennis Crouch
Janssen Biotech, Inc., 759 F.3d 1285 (Fed. [read post]
Patently-O - https://patentlyo.com
After Granting Certiorari In Enablement Case, Supreme Court Declines Opportunity To Address Written Description
11 Nov 2022, 9:40 am by Holman
Janssen Biotech, Inc., 759 F.3d 1285 (Fed. [read post]
Patently-O - https://patentlyo.com